Evaluation of aluminium, manganese, copper and selenium effects on human islets amyloid polypeptide hormone aggregation

Pakistan Journal of Biological Sciences

Volumn 14, Issue 4, 2011, Pages 288-292

  Mirhashemi, Seyyed Mehdi ^a   Shahabaddin, Mohammad Esmail ^a  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Amylin; Diabetes mellitus; Thioflavin T fluorescence; Toxic element; Trace elements

Indexed keywords

ALUMINUM; AMYLIN; COPPER; DIAGNOSTIC AGENT; MANGANESE; SELENIUM; THIAZOLE DERIVATIVE; THIOFLAVINE;

ARTICLE; CHEMISTRY; DRUG EFFECT; HUMAN;

ALUMINUM; COPPER; HUMANS; ISLET AMYLOID POLYPEPTIDE; MANGANESE; SELENIUM; THIAZOLES;

EID: 79957546998     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2011.288.292     Document Type: Article

References (27)

1. Anelli, T., M. Alessio, A. Mezghrani, T. Simmen, F. T alamo, A. Bachi and R. Sitia, 2002. ERp44, anovel endoplasmic reticulum folding assistant of the thioredoxm family. EMBO J., 21: 835-844.
2. Chan, S., B. Gerson and S. Subramanium, 1998. The role of copper, molybdenum, selenium and zinc innutrition and health. Clin. Lab. Med., 18: 673-685.
3. Crossgrove, J. and W. Zheng, 2004. Manganese toxicity upon overexposure. NMRBiomed., 17: 544-553.
4. Cumming, R.C., N.L. Andon, P.A. Haynes, M. Park, W.H. Fischer and D. Schubert, 2004. Protein disulfide bond formation in the cytoplasm during oxidative stress. J. Biol. Chem., 279: 21749-21758.
5. Erikson, K.M., K. Thompson, J. Aschner and M. Aschner, 2007. Manganese neurotoxicity. A focus on the neonate. Pharmacol. Ther., 113: 369-377.
6. Fassio, A. and R. Sitia, 2002. Formation, isomerisation and reduction of disulphide bonds during protein quality control in the endoplasmic reticulum. Histochem. Cell. Biol., 117: 151-157.
7. Gerber, G.B., A. Leonard and P. Hantson, 2002. Carcinogenicity, mutagenicity and teratogenicity of manganese compounds. Crit. Rev. Oncol. Hematol., 42: 25-34.
8. Houstis, N., E.D. Rosen and E.S. Lander, 2006. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nat, 440: 944-948.
9. Khan, A., A.E. Ashcroht, O. V. Korchazkina and C. Exley, 2004. Metal-mediated formation of fibrillar ABri amyloid. J. Inorganic Biochem., 98: 2006-2010.
10. Khan, A., A.E. Ashcroht, V. Higenell, O.V. Korchazkina and C. Exley, 2005. Metals accelerate the formation and direct the structure of amyloid fibrils of NAC. J. Inorganic Biochem., 99: 1920-1927.
11. King, H., R.E. Aubert and W.H. Herman, 1998. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates and projections. Diabetes Care, 22: 1414-1431.
12. Konarkowska, B., J.F. Aitken, J. Kistler, S. Zhang and G.J.S. Cooper, 2006. The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells. FEBS J., 273: 3614-3624.
13. Kopito, R.R. and D. Ron, 2000. Conformational disease. Nat. Cell. Biol., 2: E207-E209.
14. Lomas, D.A., D.L. Evans, J.T. Finch and R.W. Carrell, 1992. The mechanism of Z a 1-antitrypsin accumulation in the liver. Nature, 357: 605-607.
15. Lorenzo, A., B. Razzoboni, G.C. Weir and B.A. Yankner, 1994. Pancreatic islet cell toxicity of amylin associated withtype-2 diabetes mellitus. Nature, 368: 756-760.
16. Masad, A., L. Hayes, B.J. Tabner, S. Tunbull and L.J. Cooper et al, 2007. Copper mediated hydrogen peroxide from the amylin peptide: A novel mechanism for degeneration of islet cell in type-2 diabetes mellitus. FEBS Lett., 581: 3489-3493.
17. McCracken, A.A., K.B. Kruse and J.L. Brown, 1989. Molecular basis for defective secretion of the Z variant of human alpha-1-proteinase inhibitor: secretion of variants having altered potential for salt bridge formation between amino acids 290 and 342. Mol. Cell Biol, 9: 1406-1414.
18. Mirhashemi, S.M., A.A. Moshtaghie, M. Ani and M.H. Aarabi, 2009. Changes in serum, liver and brain high and low molecular weight alkaline phosphatase following manganese toxicity in rats. Toxicol. Environ. Chem., 91: 349-355.
19. Mirhashemi, S.M., A.A. Moshtaghie, M. Ani and M.H. Aarabi, 2010. In vivo and in vitro studies of kinetic changes of serum, liver and brain high and low molecular weight alkaline phosphatase following aluminium exposure inrat. Asian J. Biochem., 5: 1-11.
20. Naqshbandi, M., S.B. Harris, J.G. Esler and F. Antwi-Nsiah, 2008. Global complication rates of type 2 diabetes in Indigenous peoples: A comprehensive review. Diabetes Res. Clin. Pract, 82: 1-17.
21. Ochmanski, W. and W. Barabas, 2000. Aluminium occurrence and toxicity for organisms. Przegl. Lek., 57: 665-668.
22. Rhoades, E., J. Agarwal and A. Gafni, 2000. Aggregation of an amyloidogenic fragment of human islet amyloid polypeptide. Biochim. Biophys. Acta, 1476: 230-238.
23. Roberts, C.K. and K.K. Sindhu, 2009. Oxidative stress and metabolic syndrome. Life Sci., 84: 705-712.
24. Robrtson, R.P. and J.S. Harmon, 2007. Pancreatic islet beta-cell and oxidative stress: The importance of glutathione peroxidase. FEBS J., 581: 3743-3748.
25. Strong, M.J., R.M. Garruto, J.G. Joshi, W.R. Mundy and T.J. Shafer, 1996. Can the mechanism of aluminium neurotoxicity be integrated into a unified scheme. J. Toxicol. Environ. Health, 48: 599-614.
26. Ward, B., K. Walker and C. Exley, 2008. Copper (II) inhibits the formation of amylin amyloid in vitro. J. Inorg. Biochem., 102: 371-375.
27. Westermark, P., U. Engstrom, K.H. Johnson, G.T. Westermark and C. Betsholtz, 1990. Islet amyloid polypeptide: Pinpointing amino acid residues linked to amyloid fibril formation. Proc. Natl. Acad. Sci. USA., 87: 5036-5040.